Investment
Features
FeesSafety
Academy
More
Pluang+

El Salvador hosts Bitcoin Histórico event Nov 11-12, focusing on Bitcoin finance, payments, and AI.

Market News
19 Oct 2026
Tokenpost
View Source
Neutral
El Salvador hosts Bitcoin Histórico event Nov 11-12, focusing on Bitcoin finance, payments, and AI.

El Salvador's National Bitcoin Office is organizing Bitcoin Histórico on November 11-12 in San Salvador, featuring key events on Bitcoin finance, everyday payments, and artificial intelligence. The event includes a summit on Bitcoin's role in institutional finance, a rodeo with entertainment, and an AI conference addressing technology trends. Additionally, a Global Bitcoin Circular Economies Summit will be held in El Zonte, focusing on merchant adoption and BTC use in daily transactions. These events highlight El Salvador's ongoing commitment to integrating Bitcoin and technology into its economy.

El Salvador's Bitcoin and AI events provide context for cryptocurrency trends. For readers following major cryptocurrencies, here is Pluang's market snapshot as of Oct 20, 2026 06:02 WIB: 42 of 50 major cryptocurrencies rose today. Polkadot (DOT) is priced at Rp20.661 with a 1-day change of +4.90%, Cosmos (ATOM) at Rp31.388 with +4.80%, and MultiversX (EGLD) at Rp65.350 with +4.42%.

More News

XBiotech's phase II trial shows 61.3% 12-month survival in refractory metastatic colorectal cancer with vilamakitug.

XBiotech's phase II trial shows 61.3% 12-month survival in refractory metastatic colorectal cancer with vilamakitug.

XBiotech announced positive final efficacy results from its phase II TASKIN trial for vilamakitug (XB2001) in refractory metastatic colorectal cancer. The study, funded by the French National Cancer Institute, showed a 61.3% overall survival rate at ...

Company Fundamentals
Bullish
26 minutes ago
Phase II study shows Vilamakitug improves 12-month survival in refractory metastatic colorectal cancer.

Phase II study shows Vilamakitug improves 12-month survival in refractory metastatic colorectal cancer.

XBiotech announced positive final results from the Phase II TASKIN study, showing that adding Vilamakitug (XB2001) to standard chemotherapy improved 12-month overall survival to 61.3% in patients with refractory metastatic colorectal cancer, surpassi...

Market News
Bullish
26 minutes ago
Dorchester Minerals to acquire 4,300 net royalty acres in North Dakota's Williston Basin

Dorchester Minerals to acquire 4,300 net royalty acres in North Dakota's Williston Basin

Dorchester Minerals, L.P. has agreed to acquire mineral and royalty interests covering about 4,300 net royalty acres in three counties within North Dakota's Williston Basin. The deal involves a non-taxable contribution and exchange agreement with an ...

Company Fundamentals
Bullish
1 hour ago
Hershey Trust sells shares ahead of Q3 earnings, retaining control amid price hikes and volume drop.

Hershey Trust sells shares ahead of Q3 earnings, retaining control amid price hikes and volume drop.

The Hershey Trust Company sold 1,512 common shares under a trading plan but kept voting control through Class B shares. Hershey will report Q3 earnings on October 29, with investors focused on how price increases affected Halloween-season demand. Q2 ...

Market News
Neutral
2 hours ago
W. R. Berkley Q3 2026 earnings beat EPS estimates but revenue dips, net income down 13%.

W. R. Berkley Q3 2026 earnings beat EPS estimates but revenue dips, net income down 13%.

W. R. Berkley reported mixed Q3 2026 results with earnings per share of $1.17 beating estimates, but revenue fell short at $3.74 billion versus $3.82 billion expected. The company saw premium growth with gross premiums up 3% and net premiums up 1%, s...

Company Fundamentals
Neutral
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App